Bala Asis
Pharmacology and Drug Discovery Research Laboratory, Division of Life Sciences, Institute of Advanced Study in Science and Technology, Guwahati 781035, Assam, India.
World J Diabetes. 2024 Mar 15;15(3):572-574. doi: 10.4239/wjd.v15.i3.572.
The Advanced Glycation End Products (AGE) binding with its receptor can increase reactive oxygen species (ROS) generation through specific signaling mediators. The effect of superoxide (O) and O mediated ROS and reactive nitrogen species depends on their concentration and location of formation. Nitric oxide (NO) has anti-inflammatory and anticoagulant properties and a vasodilation effect, but NO can be deactivated by reacting with O. This reaction between NO and O produces the potent oxidant ONOO. Therefore, ONOO-'s regulatory role in AGEs in diabetic cardiovascular complications must considered as a regulator of cardiovascular complications in diabetes.
晚期糖基化终末产物(AGE)与其受体结合可通过特定信号介质增加活性氧(ROS)的生成。超氧阴离子(O)和O介导的ROS及活性氮物质的作用取决于它们的浓度和生成位置。一氧化氮(NO)具有抗炎和抗凝特性以及血管舒张作用,但NO可与O反应而失活。NO与O之间的这种反应产生强氧化剂过氧亚硝酸盐(ONOO)。因此,必须将ONOO在糖尿病心血管并发症中对AGEs的调节作用视为糖尿病心血管并发症的一种调节因素。